CURE was live on site at the the 19th Annual New York GU Cancers Congress®, where we spoke with Dr. Ulka Vaishampayan on the topic of kidney cancer. CURE was live on site at the the 19th Annual New ...

Combination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it ...

The below is a summary of a story that originally appeared on the Duke Health News website. Immunotherapy has transformed cancer care by helping the immune system recognize and destroy tumors. But new ...

SIOUX FALLS, S.D. (KELO) — People have recently been using anti-parasitic medications to help treat cancer. The Avera Cancer Institute treats hundreds of patients a year, but the hospital says it has ...

Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program ...

With the rapid introduction of novel breast cancer therapies, recognizing and managing side effects is essential to maintain adherence and improve outcomes. As novel oral endocrine therapies and ...

In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP, investigators found ...

The MarketWatch News Department was not involved in the creation of this content. Oncology/Cancer Drugs Market to Reach $335.2 Billion by 2033 Globally, at 7.2% CAGR: Allied Market Research Factors ...

Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can ...

With few treatments available to stop or reverse Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of walking back cognitive decline. Alzheimer’s cases are rising in the ...